None listed
Conditions
Brief summary
This research proposal will explore the effectiveness of using the NPS MedicineWise mobile phone application in increasing the medication adherence in chronic heart failure. In increasing the medication adherence, it is expected that patients will be able to decrease the substantial burden on healthcare services.
Interventions
This is a randomised study to measure the usefulness of a mobile phone adherence application in decreasing healthcare utility due to increased treatment adherence. Participants in the intervention arm will have access to the NPS MedicineWise application (MedicineWise app) in addition to standard care and will be trained by a member of the research team on how to use the app: this training will include navigating the app's functions. Participants in the intervention arm will be tracked on the app
This is a randomised study to measure the usefulness of a mobile phone adherence application in decreasing healthcare utility due to increased treatment adherence. Participants in the intervention arm will have access to the NPS MedicineWise application (MedicineWise app) in addition to standard care and will be trained by a member of the research team on how to use the app: this training will include navigating the app's functions. Participants in the intervention arm will be tracked on the app for 9 months (duration of the study) after which they can freely use the app for as long as they want as the app is free to download from app stores. The proposed intervention has three tiers. Tier 1: in-app medicine dose reminders from the MedicineWise app Participants will receive in-app reminders (in the form of notifications and audible alarms) when each medicine dose is due to remind them to take their dose. Participants can acknowledge that they have taken their medicine doses in the app by tapping on a “taken” button that is associated with the dose. Information of either the dose being recorded as taken or missed will be registered and recorded by the MedicineWise app. Tier 2: personalised ‘push’ notification messages from the MedicineWise app Medications have been categorised as critical or non-critical to the management of heart failure. If a participant has either missed a dose of a critical medication for 24 hours or a non-critical medication for 3 days, they will receive a personalised ‘push’ notification from the MedicineWise app containing one or more of the following messages: reminding them to take their doses; reminding them to interact with their app; emphasizing the importance of adhering with their medication regimen; how to seek help if they are having difficulty with their medication and/or operating the MedicineWise app. A research team member will examine the extracted dosage taken data during the 24 hours prior and escalate participants to the Tier 3 program as required. Tier 3: phone call intervention delivered by Medicines Line pharmacists Participants who do not respond to MedicineWise app notifications (Tier 1 intervention) and ‘push’ notification messages (Tier 2 intervention) will be contacted by a NPS MedicineWise’s Medicines Line pharmacist by telephone to discuss their medicines and medication adherence.
Sponsors
University of South Australia
Study design
Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Open (masking not used)
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
(i) age 18 years or older and able to give written informed consent; (ii) confirmed diagnosis of systolic heart failure on echocardiography (iii) NYHA functional class I-III for at least 3 months; (iv) Left ventricular ejection fraction (LVEF) < 50 % at or around the time of diagnosis of heart failure in keeping with the 2018 Australian Heart Failure guidelines (which will also include patients with an improved or recovered ejection fraction of >50% following treatment) (v) stable or stabilized condition (vi) Participant or carer with access to a smartphone or similar smart device and have adequate access for receiving and responding to emails and skype calls.
Exclusion criteria
(i) palliative heart failure (ii) NYHA functional class IV (iii) malignancy or diastolic heart failure (iv) unable to understand the study information or unable to complete outcome questionnaires (ie. if an interpreter is required) (v) life expectancy less than 6 months or patients engaged with the palliative care network (vi) use of other medication reminder app or other electronic reminder systems for daily administration of medications; (vii) participant or carer who do not have access to a smartphone or similar device or do not have adequate access for receiving and responding to emails and skype calls
Outcome results
None listed